Targeted Technology

Targeted Technology is an early-stage venture fund investing in healthcare and life-sciences companies. The firm backs businesses developing technologies intended to improve the practice of medicine and patient outcomes, with a stated focus on clinical impact and healthcare value. Its areas of interest span medical devices, life science tools, biotechnology, diagnostics, specialty pharmaceuticals, and technologies supporting life science product development and manufacturing. The firm is based in San Antonio, Texas.

In selecting investments, the fund favours technologies addressing compelling market needs and those with the potential for shorter, lower-cost paths to market. It also targets innovations that improve the efficiency, cost, or functionality of life science product development and manufacturing. The stated objective across the portfolio is to improve patient outcomes while reducing costs - a dual test that combines clinical relevance with economic argument.

The fund's stage focus is early stage; fund size, typical check size, founding year, and team composition are not disclosed. Candidates considering the firm should note the narrow sector mandate and the emphasis the firm places on market need and route-to-market economics when assessing opportunities.